M. K. Proteins Limited (NSE:MKPL)
India
· Delayed Price · Currency is INR 6.95
+0.01 (0.14%)
Apr 24, 2025, 3:29 PM IST
M. K. Proteins Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Operating Revenue | 2,174 | 2,456 | 3,149 | 2,559 | 3,111 | 1,941 | Upgrade
|
| Other Revenue | - | - | - | 0.57 | 0.48 | 2.57 | Upgrade
|
| Revenue | 2,174 | 2,456 | 3,149 | 2,559 | 3,111 | 1,944 | Upgrade
|
| Revenue Growth (YoY) | -11.78% | -22.01% | 23.02% | -17.74% | 60.07% | 24.00% | Upgrade
|
| Cost of Revenue | 1,887 | 2,164 | 2,852 | 2,383 | 2,936 | 1,877 | Upgrade
|
| Gross Profit | 286.44 | 291.41 | 296.73 | 176.15 | 175.28 | 67.05 | Upgrade
|
| Selling, General & Admin | 27.27 | 28.02 | 17.75 | 19.07 | 15.47 | 16.57 | Upgrade
|
| Other Operating Expenses | 89.68 | 93.89 | 104.45 | - | - | - | Upgrade
|
| Operating Expenses | 121.36 | 127.19 | 130.4 | 28.2 | 24.57 | 28.28 | Upgrade
|
| Operating Income | 165.09 | 164.21 | 166.33 | 147.95 | 150.71 | 38.77 | Upgrade
|
| Interest Expense | -8.28 | -10.65 | -18.42 | -8.33 | -7.5 | -14.92 | Upgrade
|
| Interest & Investment Income | 0.1 | 0.1 | 0.12 | 0.3 | - | 0.15 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 1.19 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.13 | 0.13 | 0.36 | -0 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 157.04 | 153.79 | 149.58 | 139.92 | 143.22 | 24 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.36 | 0.36 | 0.09 | 0.5 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.43 | Upgrade
|
| Other Unusual Items | 0.54 | 0.54 | 0.23 | - | - | - | Upgrade
|
| Pretax Income | 157.94 | 154.7 | 149.9 | 140.42 | 143.22 | 24.43 | Upgrade
|
| Income Tax Expense | 43.63 | 42.58 | 40.55 | 38.58 | 39.33 | 6.26 | Upgrade
|
| Net Income | 114.31 | 112.12 | 109.35 | 101.84 | 103.89 | 18.17 | Upgrade
|
| Net Income to Common | 114.31 | 112.12 | 109.35 | 101.84 | 103.89 | 18.17 | Upgrade
|
| Net Income Growth | 27.24% | 2.54% | 7.37% | -1.97% | 471.79% | 10.57% | Upgrade
|
| Shares Outstanding (Basic) | 374 | 375 | 375 | 375 | 375 | 375 | Upgrade
|
| Shares Outstanding (Diluted) | 374 | 375 | 375 | 375 | 375 | 375 | Upgrade
|
| Shares Change (YoY) | -0.47% | - | - | 0.01% | -0.01% | - | Upgrade
|
| EPS (Basic) | 0.31 | 0.30 | 0.29 | 0.27 | 0.28 | 0.05 | Upgrade
|
| EPS (Diluted) | 0.31 | 0.30 | 0.29 | 0.27 | 0.28 | 0.05 | Upgrade
|
| EPS Growth | 28.20% | 3.00% | 6.89% | -1.99% | 471.90% | 10.57% | Upgrade
|
| Free Cash Flow | - | 265.13 | -58.8 | -116.95 | 52.77 | -45.01 | Upgrade
|
| Free Cash Flow Per Share | - | 0.71 | -0.16 | -0.31 | 0.14 | -0.12 | Upgrade
|
| Gross Margin | 13.18% | 11.87% | 9.42% | 6.88% | 5.63% | 3.45% | Upgrade
|
| Operating Margin | 7.60% | 6.69% | 5.28% | 5.78% | 4.84% | 1.99% | Upgrade
|
| Profit Margin | 5.26% | 4.57% | 3.47% | 3.98% | 3.34% | 0.94% | Upgrade
|
| Free Cash Flow Margin | - | 10.80% | -1.87% | -4.57% | 1.70% | -2.31% | Upgrade
|
| EBITDA | 167.56 | 168.87 | 173.91 | 157.08 | 159.81 | 50.48 | Upgrade
|
| EBITDA Margin | 7.71% | 6.88% | 5.52% | 6.14% | 5.14% | 2.60% | Upgrade
|
| D&A For EBITDA | 2.47 | 4.66 | 7.58 | 9.13 | 9.09 | 11.71 | Upgrade
|
| EBIT | 165.09 | 164.21 | 166.33 | 147.95 | 150.71 | 38.77 | Upgrade
|
| EBIT Margin | 7.60% | 6.69% | 5.28% | 5.78% | 4.84% | 1.99% | Upgrade
|
| Effective Tax Rate | 27.62% | 27.52% | 27.05% | 27.47% | 27.46% | 25.63% | Upgrade
|
| Revenue as Reported | 2,460 | 2,460 | 3,154 | 2,560 | 3,111 | 1,944 | Upgrade
|
| Advertising Expenses | - | 0.14 | 0.04 | 0.02 | - | 0.05 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.